Journals / Turkish Journal of Family Medicine and Primary Care / 2020 / Cilt: 14 - Sayı: 3

Creutzfeldt-Jacob Disease, As aRare Cause of Dementia Should Not be Forgotten: Single-Center Experience

Pages
407–413
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Neuroimaging, serial EEG recordings, CSF analysis, and histopathologic examination should be performed for diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction:Dementia, which is an important public health problem, is divided into two groups as primary and secondary dementia.
📊
Key Findings & Data:Age, sex, complaints on admission, duration from symptom onset to mortality, neurologic examination, brainmagnetic resonance imaging (MRI), electroencephalography (EEG), and the protein 14.3.3 status of the cerebrospinal fluid(CSF) were recorded.
💡
Conclusion & Impact:Neuroimaging, serial EEG recordings, CSF analysis, and histopathologic examination should be performed for diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction:Dementia, which is an important public health problem, is divided into two groups as primary and secondary dementia. Creutzfeldt–Jakob disease (CJD), which is rarely seen, is a secondary cause of dementia with a rapidly progressive course. It is a fatal neurodegenerative disorder of infectious spongiform encephalopathy that can affect humans and animals. Sporadic CJD is the most common type that can present in four forms and has typical clinical presentations of progressive cognitive impairment, myoclonus, and ataxia. We aimed to discuss the demographic, clinical, and laboratory findings of CJD cases diagnosed in the neurointensive care unit. Methods: Sixteen patients were included in this retrospective study. Age, sex, complaints on admission, duration from symptom onset to mortality, neurologic examination, brainmagnetic resonance imaging (MRI), electroencephalography (EEG), and the protein 14.3.3 status of the cerebrospinal fluid(CSF) were recorded. Results: The mean age was61.18 ± 9.1 years (range, 37–73 years), and the most common complaints on admission were cognitive impairment, disturbance in consciousness, ataxia, and gait disturbance. CSF protein 14-3-3 was positive in 100% of patients. The most common findings were periodic sharp and wave complexeson EEG, cortical or putamen and caudate nucleus hyperintensity, cortical and cerebellar atrophyon MRI. One of the patients was diagnosed as variant CJD, and the others were diagnosed as the sporadic form. Conclusions: CJD should be kept in mind in patients with myoclonus or ataxia accompanied by progressive cognitive impairment. Neuroimaging, serial EEG recordings, CSF analysis, and histopathologic examination should be performed for diagnosis.

🔖

Cite This Article

DEMİR, T., KARA, K. A., BIÇAKÇI, Ş., PEKÖZ, M. T., BALAL, M., DEMİRKIRAN, M., BOZDEMİR, H. (2020). Creutzfeldt-Jacob Disease, As aRare Cause of Dementia Should Not be Forgotten: Single-Center Experience. Turkish Journal of Family Medicine and Primary Care, Cilt: 14 - Sayı: 3, 407–413. https://ajindex.com/articles/371263

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Green AJE. RT-QuIC: a new test for sporadic CJD. Practical Neurol 2019
  2. Feketeová E, Jarčušková D, Janáková A, Rozprávková A, Cifráková Z, Farkašová-Inaccone S et al. Creutzfeldt-Jakob Disease Surveillance in eastern Slovakia from 2004 to 2016. Cent Eur J Public Health 2018
  3. 26 (Suppl):37–41. 3.Brown P, Budka H, Cervenakova L, Collie DA, Green A, Ironside JW, et al. WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. Geneva:WHO
  4. p 12-3. 4.Brandel JP, Delasnerie-Lauprêtre N, Laplanche JL, Hauw JJ, Alpérovitch A. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology 2000
  5. 54(5):1095–9. 5.Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003
  6. 213–39 6.Johnson DY, Dunkelberger DL, Henry M, Haman A, Greicius MD, Wong K et al. Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia. JAMA Neurol. 2013
  7. 70(2):254-7. doi:10.1001/2013.jamaneurol.139 7.Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004
  8. 127(pt 10):2348-59. doi:10.1093/brain/awh249 8.Mackenzie G, Will R. Creutzfeldt-Jacob disease: recent developments. F1000Res 2017
  9. doi:10.12688/f1000research.12681.1 9.Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG, et al. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001
  10. Geschwind MD. Prion diseases. Continuum. 2015
  11. 1612–38. 11.Dervaux A, Vicart S, Lopes F, Le Borgne MH. Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropros of a case. Encephale. 2001
  12. 194–7. 12.Ukisu R, Kushihashi T, Kitanosono T, Fujisawa H, Takenaka H, Ohgiya Y, et al. Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol 2005
  13. Bavis J, Reynolds P, Tegeler C, Clark P. Asymmetric neuroimaging in Creutzfeldt-Jakob disease: a ruse. J Neuroimaging 2003
  14. 376 14.Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004
  15. Hansen HC, Zschocke S, Sturenburg HJ, Kunze K. Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in C